Abstract
With the advent and increasing availability of neuroimaging in the past few decades, cerebral venous thrombosis (CVT) has become a more easily recognized disease and appears to be more common than previously believed. Despite this, CVT remains a diagnostic and therapeutic challenge. The true incidence of CVT remains unclear. In the past the diagnosis of CVT was largely made at autopsy, leading many to believe that most cases were fatal. Early series based on angiographic diagnosis estimated mortality to be thirty to fifty percent (1,2). More recent series, however, have estimated mortality at 6–33%. Improvement in magnetic resonance imaging (MRI) and magnetic resonance venography (MRV) techniques have led to an increase in premorbid diagnosis and it has become clear that CVT is more common than previously thought. More recent studies have found death rates ranging between 5 and 30% (3–7). Furthermore, a wide range of disease symptomatology and severity may be present (3,5,8). Although this may make CVT more difficult to diagnose, recent studies suggesting effective therapy underscore the importance of prompt recognition of this elusive, but treatable cause of neurologic deterioration
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bousser M, Russell R. Cerebral Venous Thrombosis, vol 1. London: WB Saunders, 1997.
Krayenbuhl H. Cerebral venous and sinus thrombosis. Clin. Neurosurg. 1967; 14: 1–24.
Ameri A, Bousser M. Cerebral venous thrombosis. Neurol. Clin. 1992; 10: 87–111.
Daif A, Awada A, Al-Rajeh S, Abduljabbar M, et al. Cerebral venous thrombosis in adults: A study of 40 cases from Saudi Arabia. Stroke 1995; 26: 1193–1195.
Bousser M, Chiras J, Bories J, Castaigne P. Cerebral venous thrombosis: A review of 38 cases. Stroke 1985; 16: 199–213.
Thron A, Wessel K, Linden D, Schroth G, Dichgans J. Superior sagittal sinus thrombosis: Neuroradiological evaluation and clinical findings. J. Neurol. 1986; 233: 283–288.
Virapongse C, Cazenave C, Quisling R, Sarwar M, Hunter S. The empty delta sign: Frequency and significance in 76 cases of dural sinus thrombosis. Radiology 1987; 162: 779–785.
Tsai F, Wang A, Matocich V, et al. MR staging of acute dural sinus thrombosis: Correlation with venous pressure measurements and implications for treatment and prognosis. Am. J. Neuroradiol. 1995; 16: 1021–1029.
Mas J, Meder J, Meary E, Bousser M. Magnetic resonance imaging in lateral sinus hypoplasia and thrombosis. Stroke 1990; 21: 1350–1356.
Kaplan H, Browder J. Atresia of the rostral superior sagittal sinus: substitute parasagittal venous channels. J. Neurosurg. 1973; 38: 602–607.
Huber P. Cerebral Angiography. New York: Thieme, 2001.
Meder J, Chiras J, Roland J, Guinet P, Bracard S, Bargy F. Venous territories of the brain. J. Neuroradiol. 1994; 21: 118–133.
Biousse V, Bousser M. Cerebral venous thrombosis. Neurologist 1999; 5: 326–349.
Tehindrazanarivelo A, Evard S, Schaison M, Mas J-L, Dormaont D, Bousser M. Prospective study of cerebral sinus thrombosis in patients presenting with benign intracranial hypertension. Cerebrovasc. Dis. 1992; 2: 22–27.
Southwick F, Richardson EJ, Swartz M. Septic thrombosis of the dural venous sinuses. Medicine 1986; 65: 82–106.
Lew D, Southwick F, Montgomery W, Weber A, Baker A. Sphenoid sinusitis. A review of 30 cases. N. Engl. J. Med. 1983; 309: 1149–1154.
DiNubile M. Septic thrombosis of the cavernous sinuses. Arch. Neurol. 1988; 45: 567–572.
Baumgartner R, Landis T. Venous thalamic infarction. Cerebrovasc. Dis. 1992; 2: 353–358.
Haley E, Brashear H, Barth J, Cail W, Kassell N. Deep cerebral venous thrombosis: Clinical, neuroradiological, and neuropsychological correlates. Arch. Neurol. 1989; 46: 337–340.
Ur Rahman N, Al Tahan A. Computed tomographic evidence of an extensive thrombosis and infarction of the deep venous system. Stroke 1993; 24: 744–746.
Cantu C, Barinagarrementeria F. Cerebral venous thrombosis associated with pregnancy and puerperium. Review of 67 cases. Stroke 1993; 24: 1880–1884.
Villringer A, Mehraein S, Einhaupl K. Pathophysiological aspects fo cerebral sinus venous thrombosis (SVT). J. Neuroradiol. 1994; 21: 72–80.
Bousser M, Kittner S. Oral contraceptives and stroke. Cephalalgia 2000; 20: 183–189.
Lanska D, Kryscio R. Stroke and intracranial venous thrombosis during pregnancy and puerperium. Neurology 1998; 51: 1622–1628.
Srinivasan K. Cerebral venous and arterial thrombosis in pregnancy and the puerperium. A study of 135 patients. Angiology 183; 34: 731–746.
Mas J, Lamy C. Stroke in pregnancy and the puerperium. J. Neurol. 1998; 245: 305–313.
Wilder-Smith E, Kothbauere-Margreiter I, Lammle B, Sturzenegger M, Ozdoba C, Hauser S. Dural puncture and activated protein C resistance: risk factors for cerebral venous sinus thrombosis. J. Neurol. Neurosurg. Psychiatry 1997; 63: 351–356.
Jaillard A, Hommel M, Mallaret M. Venous sinus thrombosis associated with androgens in a healthy young man. Stroke 1994; 25: 212–213.
Shiozawa Z, Yamada H, Mabuchi C, Hotta T, Saito M, Sobue I et al. Superior sagittal sinus thrombosis associated with androgen therapy for hypoplastic anemia. Ann. Neurol. 1982; 12: 578–580.
Crawford J, Cotran R. The pancreas. In: Cotran R, Kumar V, Collins T, eds. Pathologic Basis of Disease. Philadelphia: WB Saunders, 2001: 902–929.
Hickey W, Garnick M, Henderson I, Dawson D. Primary cerebral venous thrombosis in patients with cancer—a rarely diagnosed paraneoplastic syndrome. Report of three cases and review of the literature. Am. J. Med. 1982; 73: 740–750.
Zuber M, Toulon P, Marnet L, Mas J. Factor V leiden mutation in cerebral venous thrombosis. Stroke 1996; 27: 1721–1723.
Martinelli I, Landi G, Merati G, Cella R, Tosetto A, Mannucci P. Factor V gene mutation is a risk factor for cerebral venous thrombosis. Thromb. Haemost. 996;75:393–394.
Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci P. High risk of cerebral vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N. Engl. J. Med. 1998; 338: 1793–1797.
Lau S, Tkachuck M, Hasegawa D, Edson J. Plasminogen and antithrombin III deficiencies in the childhood nephrotic syndrome associated with plasminogenuria and antithrombinuria. J. Pediatr. 1980; 96: 390–392.
Lau S, Bock G, Edson J, Michael A. Sagittal sinus thrombosis in the nephrotic syndrome. J. Pediatr. 1980; 97: 948–950.
Markowitz R, Ment L, Gryboski J. Cerebral thromboembolic disease in pediatric and adult inflammatory disease: case report and review of the literature. J. Pediatr. Gastroenterol. Nutr. 1989; 8: 413–420.
Vidaihet M, Piette J, Wechsler B, Bousser M, Brunet P. Cerebral venous thrombosis in systemic lupus erythematosus. Stroke 1990; 21: 1226–1231.
Laversuch C, Brown M, Clifton A, Bourke B. Cerebral venous thrombosis and acquired protein S deficiency: an uncommon cause of headache in systemic lupus erythematous. Br. J. Rheumatol. 1995; 34: 572–575.
Carhuapoma J, Mitsias P, Levine S. Cerebral venous thrombosis and anticardiolipin antibodies. Stroke 1997; 28: 2363–2369.
Sakane T, Takeno M, Suzuki N, Inaba G. Behcet’s disease. N. Engl. J. Med. 1999; 341: 1284–1291.
Aidi S, Chaunu M, Biousse V, Bousser M. Changing pattern of headache pointing to cerebral venous thrombosis after lumbar puncture and intravenous high-dose corticosteriods. Headache 1999; 39: 559–564.
Stocks G, Wooller D, Young J, Fernando R. Postpartum headache after epidural blood patch: investigation and diagnosis. Br. J. Anesth. 2000; 85: 498–499.
Newman D, Levine S, Curtis V, Welch K. Migraine-like visual phenomena associated with cerebral venous thrombosis. Headache 1989; 29: 82–85.
Purvin V, Trobe J, Kosmorsky G. Neuro-opthalmic features of cerebral venous obstruction. Arch. Neurol. 1995; 52: 880–885.
Caplan L. Posterior Circulation Disease: Clinical Findings, Diagnosis, and Management. Cambridge, MA: Blackwell Science, 1996.
Kuehnen J, Schwartz A, Neff W, Hennerici M. Cranial nerve syndrome in thrombosis of the transverse/sigmoid sinuses. Brain 1998; 121: 381–388.
Bouonanno F, Moody D, Ball M, Laster D. Computed cranial tomographic findings in cerebral sino-venous occlusion. J. Comput. Assist. Tomogr. 1978; 2: 281–290.
Patronas N, Duda E, Mirfakhraee M, Wollmann R. Superior sagittal sinus thrombosis diagnosed by computed tomography. Surg. Neurol. 1981; 15: 163–170.
Kim D, Walczak T. Computed tomography of deep cerebral venous thrombosis due to high-altitude polycythemia: Case report. J. Comput. Assist. Tomogr 1986; 10: 148–150.
Zilkha A, Stenzler S, Lin J. Computed tomography of the normal and abnormal superior sagittal sinus. Clin. Radiol. 1982; 33: 415–425.
Brant-Zawadzki M, Chang G, McCarty G. Computed tomography in dural sinus thrombosis. Arch. Neurol. 1982; 39: 446–447.
Casey S, Alberico R, Patel M, Jimenez J, Ozsvath R, Maguire W et al. Cerebral CT venography. Radiology 1996; 198: 163–170.
Wetzel S, Kirsch E, Stock K, Kolbe M, Kaim A, Radue E. Cerebral vein: comparative study of CT venography with intraarterial digital subtraction angiography. Am. J. Neuroradiol. 1999; 20: 249–255.
Mas J, Meder J, Meary E, Bousser M. Magnetic resonance imaging in lateral sinus hypoplasia and thrombosis. Stroke 1990; 21: 1350–1356.
Perkin G. Cerebral venous thrombosis: developments in imaging and treatment. J. Neurol. Neurosurg. Psychiatry 1995; 59: 1–3.
Valdueza J, Hoffmann O, Weih M, Mehraein S, Einhaupl K. Monitoring of venous hemodynamics in patients with cerebral thrombosis by transcranial doppler ultrasound. Arch. Neurol. 1995; 56: 229–234.
Valdueza JM, Harms L, Doepp F, Koscielny J, Einhaupl KM. Venous microembolic signals detected in patients with cerebral sinus thrombosis. Stroke 1997; 28: 1607–1609.
Osborn A. Stroke. Diagnostic Neuroradiology. St. Louis: Mosby, 1994: 330–400.
Brucker M, Vollert-Rogenhofer H, Wagner M, et al. Heparin treatment in acute cerebral sinus venous thrombosis: a retrospective clinical an MR analysis of 42 cases. Cerebrovasc. Dis. 1998; 8: 331–333.
Einhaupl K, Masuhr F. Cerebral venous and sinus thrombosis: an update. Eur. J. Neurol. 1994; 1: 109–126.
Einhaupl K, Villringer A, Meister W, Mehracin S, Garner C, Pelkofer M et al. Heparin treatment in sinus venous thrombosis. Lancet 1991; 338: 597–600.
Stam J, Lensing A, Vermeulen M, Tijssen J. Heparin treatment in sinus venous thrombosis. Lancet 1991; 338: 1154.
de Bruijn S, Stam J, for the Cerebral Venous Sinus Thrombosis Study Group. Randomized, placebo controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral venous thrombosis. Stroke 1999; 30: 484–488.
Bousser M. Cerebral venous thrombosis: nothing, heparin or local thrombolysis. Stroke 1999; 30: 481–483.
Frey J, Muro G, McDougall C, Dean B, Jahnke H. Cerebral venous thrombosis: combined intrathrombus rtPA and intravenous heparin. Stroke 1999; 30: 489–494.
Diaz J, Schiffman J, Urban E, Maccario M. Superior sagittal thrombosis and pulmonary embolism: a syndrome rediscovered. Acta. Neurol. Scand. 1992; 86: 390–396.
Houser O, Campbell J, Campbell R, Sundt T. Arteriovenous malformation affecting the transverse dural venous sinus. An acquired lesion. Mayo Clin. Proc. 1979; 54: 651–661.
Kalbag R, Woollf A. Cerebral Venous Thrombosis, vol 1. London: Oxford University Press, 1967.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer Science+Business Media New York
About this chapter
Cite this chapter
Marcos, Z., Sundararajan, S. (2004). Cerebral Venous Sinus Thrombosis. In: Suarez, J.I. (eds) Critical Care Neurology and Neurosurgery. Current Clinical Neurology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-660-7_21
Download citation
DOI: https://doi.org/10.1007/978-1-59259-660-7_21
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-350-3
Online ISBN: 978-1-59259-660-7
eBook Packages: Springer Book Archive